Additional £90k funding
Sepsis Research FEAT is delighted to continue to support the GenOMICC study at the University of Edinburgh’s Roslin Institute. Our aim always has been and always will be to invest in research into sepsis and critical illness to help improve outcomes and develop new treatments. GenoMICC has proven that research into genes has made a significant difference in understanding why some people get so sick with COVID, and others just get a mild infection. Our additional funding will help GenOMICC replicate this research for sepsis, and we are excited to see the results in the coming years. Read more here.